Aquatic Capital Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
+30,813
New +$1.87M 0.07% 357
2026
Q1
Sell
-3,174
Closed -$154K 1347
2025
Q4
$154K Sell
3,174
-28,124
-90% -$1.1M ﹤0.01% 1057
2025
Q3
$958K Sell
31,298
-34,512
-52% -$792K 0.02% 685
2025
Q2
$1.46M Buy
+65,810
New +$1.38M 0.03% 557
2024
Q2
Sell
-7,600
Closed -$171K 1199
2024
Q1
$171K Buy
+7,600
New +$180K 0.01% 803
2022
Q3
Sell
-1,200
Closed -$24K 1150
2022
Q2
$24K Buy
+1,200
New +$26.6K 0.01% 806

Other funds holding ANAB

Aquatic Capital Management's ANAB Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in AnaptysBio (ANAB) in Q2 2026: 30,813 shares worth $2.08M. The stake represents 0.07% of the portfolio and ranks #357 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in ANAB as recently as Q4 2025.

Aquatic Capital Management first reported a position in ANAB in Q2 2022 and has held it in 6 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Aquatic Capital Management held 30,813 shares of AnaptysBio worth $2.08M as of Q2 2026.
  • AnaptysBio was a new Aquatic Capital Management position in Q2 2026.
  • AnaptysBio made up 0.07% of Aquatic Capital Management's portfolio in Q2 2026, its #357 holding.
  • Aquatic Capital Management first reported a position in AnaptysBio in Q2 2022 and has held it in 6 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.